Extract of wax gourd peel prevents high-fat diet-induced hyperlipidemia in C57BL/6 mice via the inhibition of the PPAR γ pathway

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Gu, Ming ^a   Fan, Shengjie ^a   Liu, Gaigai ^a   Guo, Lu ^a   Ding, Xiaobo ^a,b,c   Lu, Yan ^a,b,c   Zhang, Yu ^a   Ji, Guang ^a   Huang, Cheng ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SOUTHWEST UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WAX GOURD PEEL EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE TARGETING; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID DIET; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 84875477489     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/342561     Document Type: Article

References (40)

1. Veronica G., Esther R. R., Aging, metabolic syndrome and the heart. Aging and Disease 2012 3 3 269 279
2. Fodor J. G., Frohlich J. J., Genest J. J. G., M P. R., Recommendations for the management and treatment of dyslipidemia: report of the working group on hypercholesterolemia and other dyslipidemias. Canadian Medical Association Journal 2000 162 10 1441 1447 2-s2.0-0034674011 (Pubitemid 30340311)
3. ECE D, Pharmacy Perspectives in Dyslipidemia Management 2010 US Pharmacist
4. Hasani-Ranjbar S., Nayebi N., Larijani B., Abdollahi M., A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World Journal of Gastroenterology 2009 15 25 3073 3085 2-s2.0-67651250981 10.3748/wjg.15.3073
5. Jia W., Gaoz W., Tang L., Antidiabetic herbal drugs officially approved in China. Phytotherapy Research 2003 17 10 1127 1134 2-s2.0-0346095665 10.1002/ptr.1398 (Pubitemid 38057166)
6. Sahib N. G., Saari N., Ismail A., Khatib A., Mahomoodally F., Hamid A. A., Plants' metabolites as potential antiobesity agents. The Scientific World Journal 2012 2012 8 10.1100/2012/436039 436039
7. Choudhary M., Grover K., Development of functional food products in relation to obesity. Functional Foods in Health and Disease 2012 2 188 197
8. Khare C. P., Indian Medicinal Plants: An Illustrated Dictionary 2007 Springer
9. Mathad V. S. B, Chandanam S., Setty S. R. T., Ramaiyan D., Veeranna B., Lakshminarayansettry A. B. V., Antidiarrheal evaluation of Benincasa hispida (Thunb.) Cogn. fruit extracts. Iranian Journal of Pharmacology & Therapeutics 2005 4 1
10. Sabale V., Kunjwani H., Sabale P., Formulation and in vitro evaluation of the topical antiageing preparation of the fruit of Benincasa hispida. Journal of Ayurveda and Integrative Medicine 2011 2 3 124
11. Lim S. J., Jeong J. G., Kim M. W., Choi S. S., Han H. K., Park J. E., Effects of Benincasa hispida intake on blood glucose and lipid level in streptozotocin induced diabetic rats. Korean Journal of Nutrition 2003 36 4 335 343
12. Kang K. J., Lim S. J., Jeong J. G., Han H. K., Choi S. S., Kim M. H., Kwon S. Y., Effects of wax guard on weight, triglyceride, leptin and fat cell size in rats fed on a high fat diet. Korean Journal of Nutrition 2003 36 5 446 451
13. Sreenivas K. M., Chaudhari K., Lele S. S., Ash gourd peel wax: extraction, characterization, and application as an edible coat for fruits. Food Science and Biotechnology 2011 20 2 383 387 2-s2.0-79959766061 10.1007/s10068-011-0054-1
14. Berger J. P., Akiyama T. E., Meinke P. T., PPARs: therapeutic targets for metabolic disease. Trends in Pharmacological Sciences 2005 26 5 244 251 2-s2.0-18044376795 10.1016/j.tips.2005.03.003 (Pubitemid 40603072)
15. Guo L., Tabrizchi R., Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance. Pharmacology and Therapeutics 2006 111 1 145 173 2-s2.0-33646776061 10.1016/j.pharmthera.2005.10. 009 (Pubitemid 43765533)
16. Schadinger S. E., Bucher N. L. R., Schreiber B. M., Farmer S. R., PPAR γ 2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. American Journal of Physiology 2005 288 6 E1195 E1205 2-s2.0-19444383246 10.1152/ajpendo.00513.2004 (Pubitemid 40726807)
17. Muhlhausler B. S., Morrison J. L., McMillen I. C., Rosiglitazone increases the expression of peroxisome proliferator-activated receptor- γ target genes in adipose tissue, liver, and skeletal muscle in the sheep fetus in late gestation. Endocrinology 2009 150 9 4287 4294 2-s2.0-69249090213 10.1210/en.2009-0462
18. Huang T. H. W., Kota B. P., Razmovski V., Roufogalis B. D., Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic and Clinical Pharmacology and Toxicology 2005 96 1 3 14 2-s2.0-13844314826 10.1111/j.1742-7843.2005.pto960102.x (Pubitemid 40260842)
19. Zhang Y., Fan S., Hu N., Gu M., Chu C., Li Y., Lu X., Huang C., Rhein reduces fat weight in db/db mouse and prevents diet-induced obesity in C57Bl/6 mouse through the inhibition of PPAR γ signaling. PPAR Research 2012 2012 9 10.1155/2012/374936 374936
20. Gong Z., Huang C., Sheng X., Zhang Y., Li Q., Wang M. W., Peng L., Zang Y. Q., The role of Tanshinone IIA in the treatment of obesity through peroxisome proliferator-activated receptor γ antagonism. Endocrinology 2009 150 1 104 113 2-s2.0-58149471235 10.1210/en.2008-0322
21. Goldwasser J., Cohen P. Y., Yang E., Balaguer P., Yarmush M. L., Nahmias Y., Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPAR PPAR γ and LXR PLoS ONE 2010 5 8 2-s2.0-77957871769 10.1371/journal.pone.0012399 e12399
22. Huang C., Zhang Y., Gong Z., Sheng X., Li Z., Zhang W., Qin Y., Berberine inhibits 3T3-L1 adipocyte differentiation through the PPAR γ pathway. Biochemical and Biophysical Research Communications 2006 348 2 571 578 2-s2.0-33747079990 10.1016/j.bbrc.2006.07.095 (Pubitemid 44209153)
23. Zang M., Xu S., Maitland-Toolan K. A., Zuccollo A., Hou X., Jiang B., Wierzbicki M., Verbeuren T. J., Cohen R. A., Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006 55 8 2180 2191 2-s2.0-33749349202 10.2337/db05-1188 (Pubitemid 44743614)
24. Patsouris D., Reddy J. K., Müller M., Kersten S., Peroxisome proliferator-activated receptor mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 2006 147 3 1508 1516 2-s2.0-32644443742 10.1210/en.2005-1132 (Pubitemid 43244386)
25. Yoshizumi S., Murakami T., Kadoya M., Matsuda H., Yamahara J., Yoshikawa M., Medicinal foodstuffs. XI. Histamine release inhibitors from wax gourd, the fruits of Benincasa hispida COGN. Journal of the Pharmaceutical Society of Japan 1998 118 5 188 192 2-s2.0-0031950174 (Pubitemid 28223724)
26. Dhiman K., Gupta A., Sharma D. K., Gill N. S., Goyal A., A review on the medicinally important plants of the family Cucurbitaceae. Asian Journal of Clinical Nutrition 2012 4 1 16 26 10.3923/ajcs.2012.16.26
27. Lü H., Chen J., Li W. L., Ren B. R., Wu J. L., Kang H. Y., Zhang H. Q., Adams A., De Kimpe N., Hypoglycemic and hypolipidemic effects of the total triterpene acid fraction from Folium Eriobotryae. Journal of Ethnopharmacology 2009 122 3 486 491 2-s2.0-63649128402 10.1016/j.jep.2009.01.030
28. Vasilenko I. K., Lisevitskaia L., Frolova L., Parfent'eva E., Skul'te I., Hypolipidemic properties of triterpenoids. Farmakologiia i Toksikologiia 1982 45 5 66
29. Li H., Wang Q. J., Zhu D. N., Yang Y., Reinioside C, a triterpene saponin of Polygala aureocauda Dunn, exerts hypolipidemic effect on hyperlipidemic mice. Phytotherapy Research 2008 22 2 159 164 2-s2.0-40549127848 10.1002/ptr.2262 (Pubitemid 351363232)
30. Ahmed W., Ziouzenkova O., Brown J., Devchand P., Francis S., Kadakia M., Kanda T., Orasanu G., Sharlach M., Zandbergen F., Plutzky J., PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? Journal of Internal Medicine 2007 262 2 184 198 2-s2.0-34447618831 10.1111/j.1365-2796. 2007.01825.x (Pubitemid 47087629)
31. Shi Y., Burn P., Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nature Reviews Drug Discovery 2004 3 8 695 710 2-s2.0-4344598315 (Pubitemid 39173510)
32. Furuhashi M., Hotamisligil G. S., Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nature Reviews Drug Discovery 2008 7 6 489 503 2-s2.0-44449118921 10.1038/nrd2589 (Pubitemid 351767117)
33. Wu T., Tian J., Cutler R. G., Telljohann R. S., Bernlohr D. A., Mattson M. P., Handa J. T., Knockdown of FABP5 mRNA decreases cellular cholesterol levels and results in decreased apoB100 secretion and triglyceride accumulation in ARPE-19 cells. Laboratory Investigation 2010 90 6 906 914 2-s2.0-77954589932 10.1038/labinvest.2009.33
34. Maeda K., Uysal K. T., Makowski L., Görgün C. Z., Atsumi G., Parker R. A., Brüning J., Hertzel A. V., Bernlohr D. A., Hotamisligil G. S., Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 2003 52 2 300 307 2-s2.0-0037315168 10.2337/diabetes.52.2. 300 (Pubitemid 36173182)
35. Makowski L., Boord J. B., Maeda K., Babaev V. R., Uysal K. T., Morgan M. A., Parker R. A., Suttles J., Fazio S., Hotamisligil G. S., Linton M. F., Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nature Medicine 2001 7 6 699 705 2-s2.0-0034959752 10.1038/89076 (Pubitemid 32588026)
36. Handschin C., Spiegelman B. M., Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism. Endocrine Reviews 2006 27 7 728 735 2-s2.0-33845596500 10.1210/er.2006-0037 (Pubitemid 44936056)
37. Puigserver P., Spiegelman B. M., Peroxisome proliferator-activated receptor- γ coactivator 1 (PGC-1): transcriptional coactivator and metabolic regulator. Endocrine Reviews 2003 24 1 78 90 2-s2.0-0037326196 10.1210/er.2002-0012 (Pubitemid 36223280)
38. Mitro N., Mak P. A., Vargas L., Godio C., Hampton E., Molteni V., Kreusch A., Saez E., The nuclear receptor LXR is a glucose sensor. Nature 2007 445 7124 219 223 2-s2.0-33846208252 10.1038/nature05449 (Pubitemid 46095727)
39. Edwards P. A., Kast H. R., Anisfeld A. M., BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. Journal of Lipid Research 2002 43 1 2 12 2-s2.0-0036164154 (Pubitemid 34117211)
40. Chen Y. C., Chen Y. D. I., Li X., Post W., Herrington D., Polak J. F., Rotter J. I., Taylor K. D., The HMG-CoA Reductase gene and lipid and lipoprotein levels: the multi-ethnic study of atherosclerosis. Lipids 2009 44 8 733 743 2-s2.0-68349083490 10.1007/s11745-009-3314-6